"We don't know what dose [of vaccine] will work, so we'll often start with lower doses and gradually work up until we find the appropriate level." Pfizer-BioNTech: Possible emergency use authorization by early fall Pfizer is currently recruiting children 6 months to 11 years old for its pediatric vaccine study.